Equity Research
Fundamental analysis, company comparisons, balance-sheet reviews, and equity valuation.
Coeur Mining Stock Analysis: Buy or Sell? Valuation, Cash Flow & Risk
Coeur Mining (CDE) carries a Hold rating after a strong rerating driven by higher production, metal prices, and a cleaner balance sheet. The stock screens reasonably on forward P/E, but further upside likely depends on sustained cash-flow improvement and successful New Gold integration.
Archer-Daniels-Midland Stock Analysis: Buy or Sell? Valuation, Margins & Leverage
Archer-Daniels-Midland (ADM) is rated Hold because its cash generation is solid, but margins remain thin and valuation is only fair to slightly rich. ADM’s $1.2B of TTM levered free cash flow helps support the case, yet 2.8x net debt/EBITDA and low operating margins limit upside.
Agnico Eagle Mines Stock Analysis: Buy or Sell? Valuation & Cash Flow
Agnico Eagle Mines Limited (AEM) is rated Hold as strong margins and cash generation are already priced in. The stock’s premium valuation leaves limited room for error if revenue growth keeps cooling.
Colgate-Palmolive Stock Analysis: Buy or Sell? Valuation, Margins & Cash Flow
Colgate-Palmolive (CL) is rated Hold as its quality franchise and strong margins are already reflected in the share price. The stock trades at a fair valuation, while leverage and a 1.0x current ratio limit the margin of safety.
TransDigm Group Stock Analysis: Buy or Sell? Leverage, Margins & Cash Flow
TransDigm Group (TDG) is a HOLD, with strong installed-base cash generation offset by a heavy balance sheet. Its 50.9% EBITDA margin supports the thesis, but 6.0x net debt/EBITDA limits upside and keeps refinancing risk in focus.
Kraft Heinz Stock Analysis: Buy or Sell? Valuation, FCF & Debt
Kraft Heinz (KHC) is rated Hold as strong cash generation offsets weak growth and negative net margin. Valuation looks fair, but revenue remains soft and debt is still the main risk to the thesis.
Constellium Stock Analysis: Buy or Sell? Valuation, FCF & Growth
Constellium SE (CSTM) is rated Hold as growth remains solid, but cash conversion is still too thin to justify a stronger call. The stock looks fairly valued on EV/EBITDA, yet weak free cash flow and customer concentration keep the risk profile elevated.
USA Rare Earth Stock Analysis: Buy or Sell? Valuation, Cash Burn & Growth
USA Rare Earth (USAR) earns a STRONG SELL rating as valuation races far ahead of operating reality. Revenue remains minimal while cash burn and massive capital needs keep the turnaround story dependent on execution.
Marathon Petroleum Stock Analysis: Buy or Sell? Valuation, Leverage & FCF
Marathon Petroleum (MPC) is rated Hold as strong cash generation and 13.6% operating margin are already reflected in the share price. The case hinges on whether EBITDA and free cash flow stay elevated while 1.7x net debt to EBITDA limits upside.
Boston Scientific Stock Analysis: Buy or Sell? Valuation & Growth Outlook
Boston Scientific (BSX) is rated Hold as strong organic growth and clinical momentum are offset by a valuation that already reflects much of the upside. The key question is whether BSX can keep growing fast enough to justify 13.4x EV/EBITDA while managing a $12.6B debt load.
Most Popular Research
Waitlist
Join the lf0 premium research waitlist.
More detailed equity research, scorecards, and performance analysis are coming. Add your email to be first in line.